5 matches for your search in the start-up spotlight
rss
NEOsphere Biotechnologies combines world-class mass spectrometry with expert data analysis to systematically create broad pipelines of novel degrader targets at scale and advance our partners’ targeted protein degradation (TPD) drug discovery programs at all stages. Our unique target and E3 ...
rnatics develops therapeutics that target disease-causing RNAs in tissue macrophages, which provide tremendous therapeutic opportunities for multiple diseases. Our Vision: To employ the unique natural phagocytic properties of tissue resident macrophages as an effective means of delivery to gain ...
SciRhom GmbH is a pioneering biotech enterprise with the vision to translate advanced scientific findings into game-changing therapies for autoimmune diseases. Building on a detailed understanding of how a major cell-surface protease controls inflammation, SciRhom has worked closely with Prof. ...
iOmx is a young, dynamic start-up in the field of immuno-oncology located in Martinsried/Munich, Germany. Backed by a powerful technology platform and internationally renowned investors, iOmx is driving forward a cutting-edge portfolio of early-stage novel immune-checkpoint drugs through ...
Thermosome is a clinical-stage drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a novel, proprietary tumor targeting approach that allows for significantly increased local drug concentrations and improved tumor ...
